Sandra VanlievendaelHead of Pharmaceutical Law, Legal Department at European Medicines Agency (EMA) (subject to final confirmation)
Sandra Vanlievendael joined the European Medicines Agency (EMA) in 1996 and has held different functions and responsibilities within the EMA Legal Department, ranging from Legal Advisor to Senior Legal Advisor to Head of the Pharmaceutical Section and Head of the Long Term and Special Projects Office where she has been dealing with legal questions of the Agency’s more strategic topics.
Since the restructuring of the Legal Department in August 2020, Sandra is the Head of the Pharma Law and Support to Core Business Office. Her office supports EMA’s Human and Veterinary Divisions as well as EMA’s Taskforces to achieve the Agency’s business goals whilst complying with EU pharmaceutical law in all activities. The Office is the primary contact point for the European Commission to pursue the correct legal interpretation of pharmaceutical legislation at the Agency.
Before joining the Agency Sandra worked at the European Commission within DG Research.
Sandra holds a law degree from the University of Antwerp and a Masters of European Law from the University of Liège.